Formulation and In Vitro, In Vivo Evaluation of Buccal Drug Delivery System of Tizanidine HCL

Abstract

Bio-adhesive buccal-delivery of drugs is one of alternative to the oral route of drug administration, particularly drugs that are having poor-bioavailability (BA) a first pass effect. The bioavailability of such drugs may be significantly improved if delivered through the buccal route. Tizanidine HCL is used widely for treating hypertension. The drug is well absorbed from the gastrointestinal tract but its bioavailability is low (30- 50%) due to extensive first pass metabolism. Since the buccal route bypasses the first-pass effect, the dose of Tizanidine HCL could be reduced by 50%. The physicochemical properties of Tizanidine HCL, its suitable half-life (3-7 h) a low molecular weight (196.64) used the oral route for small dose. Tizanidine HCL buccal muco-adhesive tablets were prepared by direct compression technique, using carbopol 934P, HPMC K4M as muco-adhesive polymers. Prepared formulations were evaluated for physicochemical characteristics, exvivo residence time a in-vitro release studies. Further, in vivo pharmacokinetic studies were performed in pigs.

The results of all the prepared tablets were within the acceptable pharmacopeial limits. The swelling a bio-adhesive strength values were increased a drug-release (DR) was decreased with increasing the polymer concentration. From the results, tablets with Na CMC (F2) exhibited better release, which may be due to the hydrophilicity a water uptake by the tablet a were considered as optimized formulation. The optimized formulation F2 developed with HPMC K4M released 99.62±2.24% in 6 h. The release mechanism from kinetic methods suggests that, the drug-release (DR) follows zero-order kinetics with diffusion mechanism. The drug permeation was fou to be 89.88%, while the flux a permeability coefficient of Tizanidine HCL was calculated to be 0.668 mg h−1 cm−2 a 0.056 cm h−1, respectively. DSC studies confirming that there was no interaction between the drug and other excipients.3.09-folds enhance bio-adhesive in the oral bioavailability (BA) of Tizanidine HCL from buccal tablet when compared with immediate release marketed formulation (Nepresol®). Thus, the buccal tablets of Tizanidine HCL showed enhanced BA a which was confirmed by in-vivo studies.

Introduction

As of late the enthusiasm for novel route of drug administration happens from their capacity to upgrade the bioavailability of drugs. Drug delivery by means of buccal route, utilizing bio-adhesive dose frames offers such a novel route of drug administration. Buccal-delivery includes administration of wanted drug through the buccal mucosal film coating of oralmucosa. For a long time, treatment of an intense infection or an interminable disease has been for the most part achieved by conveying drugs utilizing different pharmaceutical measurements shapes, including tablets, containers, pills, suppositories, creams, salves, fluids, mist concentrates an injectable as transporters. Among different routes of drug delivery oral route is maybe the most wanted to the patient the clinician alike. Anyway, this route shows a few issues for a couple of drugs. The compounds in the GI liquids, GIT pH conditions the proteins to GIT films are a couple of variables in charge of the bioavailability issues. The blood that depletes the GIT conveys the drug straightforwardly to the liver prompting first-pass digestion bringing about poor-bioavailability. The inalienable issues related with the drug at times can be fathomed by altering the detailing or by changing the routes of administration. Parenteral, mucosal transdermal routes evade hepatic first pass digestion offer elective routes for the fundamental delivery of drugs.

As of late, the enthusiasm for novel-routes of drug-administration happens from their capacity to improve the bioavailability of drugs. Drug-delivery by means of the buccal route utilizing bio adhesive measurement shapes offers such a novel route of drug administration. Broad first-pass digestion a drug corruption in the cruel gastrointestinal coition can be dodged by overseeing the drug by means of buccal route. Buccal-delivery includes administration of wanted drug through the buccal mucosal film covering of oral pit. The mucosal coating of oral pit offers some unmistakable favorable circumstances. It is luxuriously vascularized a progressively available for the administration a evacuation of a measurement frame. Furthermore, Buccal drug delivery has high patient agreeableness contrasted with other non-oral routes of drug administration.

Download the full article as PDF here Formulation and In Vitro, In Vivo Evaluation of Buccal Drug Delivery System of Tizanidine HCL

Materials

Tizanidine HCL was obtained as a gift sample from Dr. Reddy’s labs, Hyderabad, Telangana, India. HPMC was obtained as a gift sample from Kayel Medichem Private Limited, New Delhi, India. Carbopol 934P (granular grade) was obtained as gift sample from Neutron Drugs & Pharmaceuticals Private Limited, Hyderabad, Telangana, India.

Soudam Sai Sree, Ankit Singh, Gollapudi Rajesh, Formulation and In Vitro, In Vivo Evaluation of Buccal Drug Delivery System of Tizanidine HCL, GMR